ABBVIE INC (4AB.DE) Stock Fundamental Analysis

FRA:4AB • US00287Y1091

193.8 EUR
+5.4 (+2.87%)
Last: Feb 27, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

Taking everything into account, 4AB scores 5 out of 10 in our fundamental rating. 4AB was compared to 75 industry peers in the Biotechnology industry. 4AB has an excellent profitability rating, but there are concerns on its financial health. 4AB may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • 4AB had positive earnings in the past year.
  • In the past year 4AB had a positive cash flow from operations.
  • In the past 5 years 4AB has always been profitable.
  • Each year in the past 5 years 4AB had a positive operating cash flow.
4AB.DE Yearly Net Income VS EBIT VS OCF VS FCF4AB.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

1.2 Ratios

  • 4AB has a better Return On Assets (3.12%) than 76.62% of its industry peers.
  • 4AB's Return On Invested Capital of 14.42% is amongst the best of the industry. 4AB outperforms 92.21% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for 4AB is in line with the industry average of 12.19%.
  • The 3 year average ROIC (12.12%) for 4AB is below the current ROIC(14.42%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.12%
ROE N/A
ROIC 14.42%
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
4AB.DE Yearly ROA, ROE, ROIC4AB.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100 -100

1.3 Margins

  • Looking at the Profit Margin, with a value of 6.84%, 4AB is in the better half of the industry, outperforming 76.62% of the companies in the same industry.
  • In the last couple of years the Profit Margin of 4AB has declined.
  • 4AB has a Operating Margin of 34.23%. This is amongst the best in the industry. 4AB outperforms 88.31% of its industry peers.
  • In the last couple of years the Operating Margin of 4AB has grown nicely.
  • With a decent Gross Margin value of 71.62%, 4AB is doing good in the industry, outperforming 62.34% of the companies in the same industry.
  • In the last couple of years the Gross Margin of 4AB has remained more or less at the same level.
Industry RankSector Rank
OM 34.23%
PM (TTM) 6.84%
GM 71.62%
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
4AB.DE Yearly Profit, Operating, Gross Margins4AB.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • 4AB has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, 4AB has about the same amount of shares outstanding.
  • The number of shares outstanding for 4AB remains at a similar level compared to 5 years ago.
  • The debt/assets ratio for 4AB is higher compared to a year ago.
4AB.DE Yearly Shares Outstanding4AB.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
4AB.DE Yearly Total Debt VS Total Assets4AB.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.2 Solvency

  • 4AB has an Altman-Z score of 2.45. This is not the best score and indicates that 4AB is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of 4AB (2.45) is better than 66.23% of its industry peers.
  • The Debt to FCF ratio of 4AB is 3.79, which is a good value as it means it would take 4AB, 3.79 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of 4AB (3.79) is better than 83.12% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.79
Altman-Z 2.45
ROIC/WACC1.78
WACC8.08%
4AB.DE Yearly LT Debt VS Equity VS FCF4AB.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B 40B 60B

2.3 Liquidity

  • A Current Ratio of 0.67 indicates that 4AB may have some problems paying its short term obligations.
  • 4AB's Current ratio of 0.67 is on the low side compared to the rest of the industry. 4AB is outperformed by 77.92% of its industry peers.
  • 4AB has a Quick Ratio of 0.67. This is a bad value and indicates that 4AB is not financially healthy enough and could expect problems in meeting its short term obligations.
  • 4AB has a worse Quick ratio (0.56) than 77.92% of its industry peers.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.56
4AB.DE Yearly Current Assets VS Current Liabilites4AB.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • 4AB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.19%.
  • The Earnings Per Share has been decreasing by -0.99% on average over the past years.
  • 4AB shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.57%.
  • The Revenue has been growing slightly by 5.95% on average over the past years.
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.77% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 6.33% on average over the next years.
EPS Next Y45.22%
EPS Next 2Y27.48%
EPS Next 3Y21.41%
EPS Next 5Y14.77%
Revenue Next Year10.06%
Revenue Next 2Y9.25%
Revenue Next 3Y8.61%
Revenue Next 5Y6.33%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4AB.DE Yearly Revenue VS Estimates4AB.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B
4AB.DE Yearly EPS VS Estimates4AB.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 22.88, 4AB is valued on the expensive side.
  • 81.82% of the companies in the same industry are more expensive than 4AB, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of 4AB to the average of the S&P500 Index (27.07), we can say 4AB is valued inline with the index average.
  • A Price/Forward Earnings ratio of 15.75 indicates a correct valuation of 4AB.
  • 4AB's Price/Forward Earnings ratio is rather cheap when compared to the industry. 4AB is cheaper than 94.81% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.05, 4AB is valued a bit cheaper.
Industry RankSector Rank
PE 22.88
Fwd PE 15.75
4AB.DE Price Earnings VS Forward Price Earnings4AB.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 81.82% of the companies in the same industry are more expensive than 4AB, based on the Enterprise Value to EBITDA ratio.
  • 4AB's Price/Free Cash Flow ratio is rather cheap when compared to the industry. 4AB is cheaper than 87.01% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.7
EV/EBITDA 15.96
4AB.DE Per share data4AB.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • 4AB has a very decent profitability rating, which may justify a higher PE ratio.
  • 4AB's earnings are expected to grow with 21.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.51
PEG (5Y)N/A
EPS Next 2Y27.48%
EPS Next 3Y21.41%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • 4AB has a Yearly Dividend Yield of 3.08%.
  • 4AB's Dividend Yield is rather good when compared to the industry average which is at 0.62. 4AB pays more dividend than 97.40% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, 4AB pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.08%

5.2 History

  • On average, the dividend of 4AB grows each year by 6.76%, which is quite nice.
Dividend Growth(5Y)6.76%
Div Incr Years4
Div Non Decr Years4
4AB.DE Yearly Dividends per share4AB.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 2026 2 4 6

5.3 Sustainability

  • 278.48% of the earnings are spent on dividend by 4AB. This is not a sustainable payout ratio.
  • The dividend of 4AB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP278.48%
EPS Next 2Y27.48%
EPS Next 3Y21.41%
4AB.DE Yearly Income VS Free CF VS Dividend4AB.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B
4AB.DE Dividend Payout.4AB.DE Dividend Payout, showing the Payout Ratio.4AB.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ABBVIE INC

FRA:4AB (2/27/2026, 7:00:00 PM)

193.8

+5.4 (+2.87%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-04
Earnings (Next)04-23
Inst Owners75.04%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap342.52B
Revenue(TTM)61.16B
Net Income(TTM)4.19B
Analysts77.3
Price Target216.59 (11.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.08%
Yearly Dividend5.59
Dividend Growth(5Y)6.76%
DP278.48%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.46%
Min EPS beat(2)0.18%
Max EPS beat(2)2.75%
EPS beat(4)4
Avg EPS beat(4)1.25%
Min EPS beat(4)0.18%
Max EPS beat(4)2.75%
EPS beat(8)8
Avg EPS beat(8)1.12%
EPS beat(12)10
Avg EPS beat(12)0.74%
EPS beat(16)12
Avg EPS beat(16)0.58%
Revenue beat(2)0
Avg Revenue beat(2)-0.79%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)-0.78%
Revenue beat(4)2
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.21%
Revenue beat(12)5
Avg Revenue beat(12)0.03%
Revenue beat(16)5
Avg Revenue beat(16)-0.64%
PT rev (1m)1.65%
PT rev (3m)0.72%
EPS NQ rev (1m)-3.73%
EPS NQ rev (3m)-1.78%
EPS NY rev (1m)0.03%
EPS NY rev (3m)0.06%
Revenue NQ rev (1m)-1.75%
Revenue NQ rev (3m)-1.02%
Revenue NY rev (1m)0.31%
Revenue NY rev (3m)1.17%
Valuation
Industry RankSector Rank
PE 22.88
Fwd PE 15.75
P/S 6.61
P/FCF 22.7
P/OCF 21.25
P/B N/A
P/tB N/A
EV/EBITDA 15.96
EPS(TTM)8.47
EY4.37%
EPS(NY)12.3
Fwd EY6.35%
FCF(TTM)8.54
FCFY4.41%
OCF(TTM)9.12
OCFY4.71%
SpS29.31
BVpS-1.57
TBVpS-43.88
PEG (NY)0.51
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 3.12%
ROE N/A
ROCE 23.09%
ROIC 14.42%
ROICexc 15.28%
ROICexgc N/A
OM 34.23%
PM (TTM) 6.84%
GM 71.62%
FCFM 29.13%
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
ROICexc(3y)13.19%
ROICexc(5y)12.96%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.1%
ROCE(5y)18.64%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y5.79%
ROICexc growth 5Y14.56%
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
F-Score8
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.79
Debt/EBITDA 2.11
Cap/Depr 14.92%
Cap/Sales 1.98%
Interest Coverage 6.97
Cash Conversion 65.45%
Profit Quality 425.61%
Current Ratio 0.67
Quick Ratio 0.56
Altman-Z 2.45
F-Score8
WACC8.08%
ROIC/WACC1.78
Cap/Depr(3y)11.82%
Cap/Depr(5y)10.58%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.55%
Profit Quality(3y)434.7%
Profit Quality(5y)340.33%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
EPS Next Y45.22%
EPS Next 2Y27.48%
EPS Next 3Y21.41%
EPS Next 5Y14.77%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%
Revenue Next Year10.06%
Revenue Next 2Y9.25%
Revenue Next 3Y8.61%
Revenue Next 5Y6.33%
EBIT growth 1Y26.92%
EBIT growth 3Y1.33%
EBIT growth 5Y8.87%
EBIT Next Year42.03%
EBIT Next 3Y19.48%
EBIT Next 5Y10.36%
FCF growth 1Y-0.09%
FCF growth 3Y-9.76%
FCF growth 5Y1.19%
OCF growth 1Y1.19%
OCF growth 3Y-8.62%
OCF growth 5Y1.59%

ABBVIE INC / 4AB.DE FAQ

What is the ChartMill fundamental rating of ABBVIE INC (4AB.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to 4AB.DE.


What is the valuation status for 4AB stock?

ChartMill assigns a valuation rating of 7 / 10 to ABBVIE INC (4AB.DE). This can be considered as Undervalued.


How profitable is ABBVIE INC (4AB.DE) stock?

ABBVIE INC (4AB.DE) has a profitability rating of 6 / 10.


Can you provide the financial health for 4AB stock?

The financial health rating of ABBVIE INC (4AB.DE) is 4 / 10.


How sustainable is the dividend of ABBVIE INC (4AB.DE) stock?

The dividend rating of ABBVIE INC (4AB.DE) is 6 / 10 and the dividend payout ratio is 278.48%.